You have 9 free searches left this month | for more free features.

Cyclophosphamide

Showing 1 - 25 of 4,409

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial (Nanoxel M, Taxotere, Doxorubicin)

Not yet recruiting
  • Breast Cancer
  • Nanoxel M
  • +3 more
  • (no location specified)
Jan 20, 2022

Fallopian Tube Cancer, Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Duarte, Pasadena

Active, not recruiting
  • Fallopian Tube Cancer
  • +2 more
  • Duarte, California
  • +1 more
Mar 17, 2022

Idiopathic Membranous Nephropathy Trial (Rituximab, Cyclophosphamide)

Not yet recruiting
  • Idiopathic Membranous Nephropathy
  • (no location specified)
Aug 22, 2022

Acute Leukemia, MDS Trial in Chicago (device, drug, other)

Recruiting
  • Acute Leukemia
  • MDS
  • Arm1
  • Arm 1
  • Chicago, Illinois
    University of Illinois Cancer Center
Jul 7, 2022

Lymphoma Trial in Houston (2CdA, Cyclophosphamide, Rituximab)

Completed
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2022

Breast Cancer, Chemotherapeutic Toxicity Trial in Hanzhou (Liposomal doxorubicin + Cyclophosphamide vs Docetaxel +

Recruiting
  • Breast Cancer
  • Chemotherapeutic Toxicity
  • Liposomal doxorubicin + Cyclophosphamide vs Docetaxel + Cyclophosphamide
  • Hanzhou, Zhejing, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Apr 7, 2022

Localized Breast Cancer Trial in Dijon (Dense dose epirubicin-cyclophosphamide chemo and G-CSF (filgrastim, lenograstim), Dense

Not yet recruiting
  • Localized Breast Cancer
  • Dense dose epirubicin-cyclophosphamide chemotherapy and G-CSF (filgrastim, lenograstim)
  • Dense dose epirubicin-cyclophosphamide chemotherapy with administration of peg-G-CSF (pegfilgrastim)
  • Dijon, Bourgogne, France
    Centre Georges François Leclerc (CGFL)
Mar 24, 2022

Chronic Inflammatory Demyelinating Polyneuropathy Trial (Cyclophosphamide)

Withdrawn
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Cyclophosphamide
  • (no location specified)
Nov 2, 2021

Relapsed/Refractory Multiple Myeloma Trial in Baltimore (Belantamab Mafodotin, Cyclophosphamide and Dexamethasone)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Belantamab Mafodotin, Cyclophosphamide and Dexamethasone
  • Baltimore, Maryland
    University of Maryland
Jan 24, 2022

Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention)

Active, not recruiting
  • Graft-versus-host Disease
  • Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention
  • New York, New York
    NYU Langone Health
Aug 5, 2022

Hematological Malignancy Trial in Detroit (Bortezomib)

Recruiting
  • Hematological Malignancy
  • Detroit, Michigan
    Henry Ford hospital
Dec 23, 2021

Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)

Recruiting
  • Refractory Solid Tumor
  • +4 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 4, 2022

Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy

Completed
  • Lupus Nephritis
  • Cairo, Egypt
    Kasr El Aini Hospital
Jan 4, 2022

Multiple Myeloma Trial in Torino (Pomalidomide, Cyclophosphamide, Prednisone)

Active, not recruiting
  • Multiple Myeloma
  • Pomalidomide, Cyclophosphamide, Prednisone
  • Torino, Italy
    AOU Città della Salute e della Scienza di Torino - SC Ematologia
Mar 24, 2022

Multiple Myeloma Trial in Torino (Carfilzomib, Cyclophosphamide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Fondazione EMN Italy Onlus
Mar 24, 2022

Graft Vs Host Disease Trial in New York (Cyclophosphamide, Abatacept, Tacrolimus)

Recruiting
  • Graft Vs Host Disease
  • Cyclophosphamide
  • +2 more
  • New York, New York
    NYU Langone Health
Nov 10, 2022

Severe Aplastic Anemia Trial in Atlanta (Fludarabine, Cyclophosphamide, Total Body Irradiation)

Recruiting
  • Severe Aplastic Anemia
  • Atlanta, Georgia
  • +1 more
Apr 4, 2022

Metastatic Renal Cell Carcinoma Trial in United Kingdom (Cyclophosphamide 50mg, Pembrolizumab 25 mg/1 ML Intravenous Solution

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Cyclophosphamide 50mg
  • Pembrolizumab 25 mg/1 ML Intravenous Solution [KEYTRUDA]
  • Cambridge, United Kingdom
  • +3 more
Aug 22, 2022

GVHD Trial in Hackensack (Cyclophosphamide and Sirolimus, Low dose IL-2 with Cytoxan + Sirolimus, Low dose IL-2, low dose

Terminated
  • Graft Versus Host Disease
  • Cyclophosphamide and Sirolimus
  • +3 more
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Feb 4, 2022

Tofatib Treatment for IgG4-related Disease

Recruiting
  • IgG4-related Disease
  • Shanghai, Shanghai, China
    Shanghai Changhai Hospital
Nov 15, 2022

Multiple Myeloma Trial in Torino (Carfilzomib, Cyclophosphamide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Fondazione EMN Italy Onlus
Mar 24, 2022

Idiopathic Pulmonary Fibrosis Trial in Paris (Cyclophosphamide, Placebo, Corticosteroid (prednisolone))

Completed
  • Idiopathic Pulmonary Fibrosis
  • Cyclophosphamide
  • +2 more
  • Paris, France
    Hôpital Tenon
Jun 27, 2022

Systemic Scleroderma Trial in Duarte (procedure, drug, radiation)

Recruiting
  • Systemic Scleroderma
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 7, 2022

Hematopoietic Stem Cell Transplantation Trial (Drug: Cyclophosphamide)

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • Drug: Cyclophosphamide
  • (no location specified)
Jun 22, 2021

Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +5 more
  • GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
  • (no location specified)
Aug 23, 2022